Skip Nav Destination
Issues
1 December 2015
-
Cover Image
Cover Image
Adipose is a metabolically active and complex tissue consisting of macrophages, lymphocytes, endothelium, mesenchymal stem cells, and mature adipocytes. There are significant structural and functional differences between adipose derived from lean and obese humans. Adipose from obese humans with metabolic syndrome secretes a very different milieu of active cytokines, compared to healthy adipose. Culturing mature intact adipose tissue derived from adipose biopsies or surgically resected organs presents new opportunities to study the complex signals between adipose and epithelia. Normal human adipose adapts well in contemporary 3-dimensional culture technologies. The micrograph shown on the cover (40× magnification) shows intact mammary adipose stained for actin (red) and neutral fatty acids with BODIPY493/503 (green) to identify adipocytes. Conditioned media collected from adipose in culture enables analysis of the secretome and further exploration of both paracrine and endocrine effects of adipose-derived cytokines on vulnerable epithelial targets. The publication of Esper et al. (p. 1174) in this issue of Cancer Prevention Research reports that leptin secretion from human adipose correlates with expansion of normal human mammary stem cell spheres. Adipose-derived adiponectin is inversely correlated with normal human mammary stem cell sphere formation. This model provides a useful platform for studies aimed at dissecting the relationship between the obesity-associated metabolic syndrome and carcinogenesis. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Research Articles
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus
Andrew K. Joe; Felice Schnoll-Sussman; Robert S. Bresalier; Julian A. Abrams; Hanina Hibshoosh; Ken Cheung; Richard A. Friedman; Chung S. Yang; Ginger L. Milne; Diane D. Liu; J. Jack Lee; Kazeem Abdul; Michelle Bigg; Jessica Foreman; Tao Su; Xiaomei Wang; Aqeel Ahmed; Alfred I. Neugut; Esther Akpa; Scott M. Lippman; Marjorie Perloff; Powel H. Brown; Charles J. Lightdale
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick; Vikrant V. Sahasrabuddhe; Andrew T. Chan; Michael C. Alavanja; Laura E. Beane-Freeman; Julie E. Buring; Jie Chen; Dawn Q. Chong; Neal D. Freedman; Charles S. Fuchs; John Michael Gaziano; Edward Giovannucci; Barry I. Graubard; Albert R. Hollenbeck; Lifang Hou; Eric J. Jacobs; Lindsay Y. King; Jill Koshiol; I-Min Lee; Martha S. Linet; Julie R. Palmer; Mark P. Purdue; Lynn Rosenberg; Catherine Schairer; Howard D. Sesso; Alice J. Sigurdson; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Peter T. Campbell; Katherine A. McGlynn
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.